Investing.com - Morphosys AG reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Morphosys AG announced earnings per share of €-1.45 on revenue of €47.2M. Analysts polled by Investing.com anticipated EPS of €-1.37 on revenue of €44.3M.
Morphosys AG shares are down 22% from the beginning of the year, still down 42.13% from its 52 week high of €125.20 set on July 21, 2020. They are under-performing the STOXX 600 which is up 10.14% from the start of the year.
Morphosys AG follows other major Healthcare sector earnings this month
Morphosys AG's report follows an earnings missed by Siemens Healthineers on Monday, who reported EPS of €0.44 on revenue of €3.97B, compared to forecasts EPS of €0.4647 on revenue of €3.9B.
Fresenius Medical Care had beat expectations on Thursday with first quarter EPS of €0.85 on revenue of €4.21B, compared to forecast for EPS of €0.7776 on revenue of €4.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar